Iversen, Edwin S. Jr. http://orcid.org/0000-0002-0066-2763
Lipton, Gary
Hart, Steven N. http://orcid.org/0000-0001-7714-2734
Lee, Kun Y. http://orcid.org/0000-0002-0684-8112
Hu, Chunling
Polley, Eric C.
Pesaran, Tina http://orcid.org/0000-0001-9807-4304
Yussuf, Amal
LaDuca, Holly
Chao, Elizabeth
Karam, Rachid http://orcid.org/0000-0002-5645-498X
Goldgar, David E.
Couch, Fergus J.
Monteiro, Alvaro N. A. http://orcid.org/0000-0002-8448-4801
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01CA116167, P50CA116201, R01CA116167, P50CA116201, P50CA116201, P50CA116201, P50CA116201, R01CA116167, R01CA116167)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
DH | NIHR | Efficacy and Mechanism Evaluation Programme (R35CA253187)
Article History
Received: 26 February 2021
Accepted: 4 May 2022
First Online: 3 June 2022
Competing interests
: T.P., A.Y., H.L., E.C., and R.K. were employees of Ambry Genetics during the time this study was conducted. The remaining authors declare no competing interests.